A Study to Assess the Safety and Pharmacokinetics of AD-104-A
NCT05703282 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2024-08-01
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-104-A
Conditions
- Hyperlipidemias
Interventions
- DRUG
-
AD-104-A
PO, Single-Dose, AD-104-A
Sponsors & Collaborators
-
Addpharma Inc.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-13
- Primary Completion
- 2024-04-05
- Completion
- 2024-04-05
Countries
- South Korea
Study Locations
More Related Trials
-
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
NCT03920579 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
NCT04987970 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
NCT03849287 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348
NCT04258865 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
NCT07312799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT04883658 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers
NCT01043094 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
NCT04019743 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03210649 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
NCT05552495 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers
NCT03671941 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Pharmacokinetics and Safety of CKD-391
NCT04354987 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Profile of CKD-333
NCT03659149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04183686 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02753504 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT04083846 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
NCT06399068 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
NCT04304547 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers
NCT05370950 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT03849261 ·Status: UNKNOWN ·Phase: PHASE1
-
Absorption, Metabolism, Excretion and Absolute Bioavailability
NCT03250039 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
NCT03646799 ·Status: UNKNOWN ·Phase: PHASE1
-
Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
NCT02484482 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT05335044 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers
NCT04975711 ·Status: COMPLETED ·Phase: PHASE1